PBMs are transparent and reduce drug costs in New Jersey The Pharmaceutical Care Management Association (PCMA) issued the following statement on New Jersey Governor Mikie Sherrill’s budget address: “The governor’s remarks today about pharmacy benefit managers (PBMs) are simply untrue
Now, Congress Should Make Biosimilars Interchangeable (Washington, D.C.) – The Trump Administration is taking action to increase access to biosimilars. Congress can take the administration’s lead and entirely eliminate the interchangeability designation for biosimilars. In response to the new draft guidance, issued
(Washington, D.C) – Several state legislatures and some federal lawmakers have considered a dangerous policy, known as “Forced Pharmacy Closure,” that bars integration between pharmacy benefit managers and pharmacies. If implemented, the result – shutting down hundreds or thousands of pharmacies
At a House Energy and Commerce subcommittee hearing last week, the full pharmaceutical drug supply chain testified, including a group that professes to represent employer interests. In one of the more fascinating exchanges, a member of the subcommittee sought to
Congress recently enacted government mandates on employers and pharmacy benefit managers (PBMs) – the ones who counter the pricing power of Big Pharma and deliver savings for American patients and employers. This intervention, dictating contract terms for employers and PBMs,
Earlier this month, the president signed into law significant new mandates on employers and pharmacy benefit managers – full PBM transparency, full rebate pass-through, Medicare delinking. These were big wins for the big drugmakers who’ve long invested heavily in diverting
Competitive Enterprise Institute February 10, 2026 In the recently passed appropriations bill, Congress enacted several Pharmacy Benefit Manager (PBM) reforms it has been contemplating for years. On the surface, these reforms appear reasonable, but on closer examination, they will likely do
(Washington, D.C.) — Today, David Marin, President and CEO of PCMA, joined a hearing at the Energy and Commerce Health Subcommittee focused on prescription drug affordability. The hearing, following the recent enactment of significant pharmacy benefit manager (PBM) legislation, includes
Employers report high satisfaction with drug savings PBMs get and the transparency they provide (Washington, D.C.) — A new survey released today shows American employers are highly satisfied with their pharmacy benefit manager (PBM) relationship. The survey results found PBMs are
(Washington, D.C.) — Today, the Pharmaceutical Care Management Association (PCMA) released new data that provides a snapshot of the health of independent pharmacies in the United States. The findings reveal that the overall number of independent pharmacies in the U.S. grew
